A rating towards 1-2 suggests a Consensus Buy whereas rating between 3 and 5 implies Hold and Sell opinion for a stock.
Sell-side analysts on Wall Street covering shares of CVS Health Corporation (NYSE:CVS) have handed the stock a one year target price of $117.352.
In other Colfax Corp news, CEO Clay Kiefaber sold 198,873 shares of the company's stock in a transaction on Tuesday, November 24th. The shares were sold at an average price of $45.32, for a total value of $152,955.00. Vicus Capital now owns 7,471 shares of the company's stock valued at $323,000 after buying an additional 1,430 shares during the last quarter. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The stock was acquired at an average cost of $23.41 per share, for a total transaction of $234,100.00. Following the completion of the sale, the director now directly owns 28,084 shares in the company, valued at $1,316,858.76. The disclosure for this purchase can be found here.
Other institutional investors recently added to or reduced their stakes in the company. Meeder Asset Management now owns 17,215 shares of the company's stock valued at $454,000 after buying an additional 2,096 shares during the period. Capstone Asset Management Company bought a new stake in Stifel Financial Corp during the fourth quarter valued at about $260,000. Alpha Windward boosted its stake in Ameren Corp by 4,254.5% in the fourth quarter. Churchill Management now owns 322,882 shares of the company's stock valued at $13,958,000 after buying an additional 23,515 shares during the last quarter.
Several equities analysts have weighed in on SF shares. Barclays decreased their price objective on Colfax Corp to $22.00 and set an underweight rating on the stock in a report on Wednesday, December 23rd.
As per the most recent update, the company is set to announce its next quarter report on or around 2016-02-02. RBC Capital dropped their price target on Teradata from $33.00 to $30.00 and set a "sector perform" rating for the company in a research note on Friday, November 6th. The current rating of the shares is Neutral. The consensus estimate for Ameren Corp's Q4 2015 earnings is $0.21 per share. 583,672 shares of the company traded hands. This ratio abbreviated as P/E ratio assesses stock's performance compared to its price. After the session commenced at $8.9, the stock reached the higher end at $9 while it hit a low of $8.7. CNA Financial Corporation (NYSE:CNA) recorded an average volume of 118937 over the last 3 months. As per Thomson Reuters First Call, the earnings for the next quarter has been stated at 0.77 per share. During the same period in the previous year, the company earned $0.64 EPS. The business's quarterly revenue was up 9.8% on a year-over-year basis. Finally, PGGM Investments increased its position in shares of Teradata by 1.6% in the fourth quarter. As per analysts, the company can post earnings of $0.05 per share in next quarter and $0.25 in current fiscal.
Ameren Corporation (NYSE:AEE) is a utility holding company. The Company, through its subsidiaries, operates in two segments: Marine Transportation and Diesel Engine Services. The Company's segments include gas and fluid handling, and fabrication technology.
David Bowie impersonates Tom Waits, Lou Reed on newly discovered recording
So, it comes as little surprise that Bowie - who died on January 10 at the age of 69 - was an expert mimic of other singers. But this newly discovered recording of the singer messing around during a 1985 recording session is, nonetheless, charming.
$57.5 Price Target Assigned To Lazard Ltd. (NYSE:LAZ)
